Researchers at a medical research firm affiliated to the University of Bristol say that they have identified a new method of fighting the spread of cancer. The scientists looked at the natural life cycle of cells, one of the key biological processes linked to cancer growth. In particular they focused on a molecule known as protein kinase B (PKB) that is found in all cells.
In a study of nonhuman primates infected with the influenza virus that killed 50 million people in 1918, an international team of scientists has found a critical clue to how the virus killed so quickly and efficiently.
Eosinophilic esophagitis (EE) is disease that was first described in children only 20 years ago, but has shown a rising incidence in both children and adults. An inflammatory condition of the esophagus, its symptoms including vomiting, heartburn and difficulty in swallowing.
A group of researchers has discovered a number of children suffering from rare muscle diseases whose bodies have “switched on” a gene that is usually turned off at birth.
CNRS (France) researchers have developed a novel synthetic process for bio degradeable materials that could be used instead of traditional medication in the form of tablets, capsules or syrups. This study was published on 27 December 2006 in the Journal of the American Chemical society.
Scientists at Monash University in Australia have developed a process for rapidly and efficiently separating blood plasma at the microscopic level without any moving parts, potentially allowing doctors to do blood tests without sending samples to a laboratory.
A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease. The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory.
The freeze-frame image of a molecular relay race, in which one enzyme passes off a protein like a baton to another enzyme, has solved a key mystery to how cells control some vital functions, according to investigators at St. Jude Children’s Research Hospital. A report on this work appears in the January 14 advanced online publication issue of Nature.
Researchers at Virginia Commonwealth University’s Massey Cancer Center have created a new method to improve the antileukemic activity of a novel agent that triggers programmed cell death, a development that could lead to more effective strategies for fighting leukemia and other malignancies.
Three studies independently characterize the genetic diversity of the parasite that causes malaria in the January issue of Nature Genetics.